Gilvan Pessoa Furtado
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Gilvan Pessoa Furtado has a total of 56 co-authors. Here are the top co-authors by number of shared publications:
- Larissa Queiroz Pontes
Protein Engineering and Health Solutions Group, Oswaldo Cruz Foundation, Fiocruz Ceará, Eusébio, Ceará, 61.773-270, Brazil
3 shared publications Ana Virgínia Frota Guimarães de Aquino
Protein Engineering and Health Solutions Group (GEPeSS), Oswaldo Cruz Foundation (Fiocruz), Eusébio, Ceará, Brazil; Graduate Program in Biosciences and Biotechnology, Carlos Chagas Institute / Fiocruz Paraná, Curitiba, Paraná, Brazil
2 shared publicationsMarcus Rafael Lobo Bezerra
Protein Engineering and Health Solutions Group (GEPeSS), Oswaldo Cruz Foundation (Fiocruz), Eusébio, Ceará, Brazil
2 shared publications- Marcus Rafael Lobo Bezerra
Oswaldo Cruz Foundation, Fiocruz Ceará, Eusébio 61773-270, Brazil
2 shared publications - Adalberto Socorro da Silva
Universidade Federal do Piauí
1 shared publication Alice Soares de Queiroz
Protein Engineering and Health Solutions Group, Oswaldo Cruz Foundation, Fiocruz Ceará, Eusébio, Ceará, CEP 61.773-270, Brazil; Postgraduate Program in Biotechnology of Natural Resources, Federal University of Ceará, Campus do Pici, 825, Fortaleza, Ceará, CEP 60.440-970, Brazil
1 shared publication
Latest Publications
- Open Access
- 1 March 2026
- Published by American Association for the Advancement of Science (AAAS) in Computational and Structural Biotechnology Journal
- Vol. 35 (1)
Revisiting the Ofatumumab Epitope on CD20 through Integrative Molecular Dynamics and Flow Cytometry Analyses
Highlights: • How does ofatumumab recognize CD20? Revisiting conflicting epitope models from Teeling, Du, and Kumar • Integrative approach combining molecular dynamics, free-energy decomposition, and flow cytometry validation • MD and Δ G _res analyses define an ECL2b-centered epitope consistent with cryo-EM observations by Kumar et al. • Residues Tyr107, Asp99, Tyr169, and Arg228 form a stabilizing hydrophobic–electrostatic cluster in the paratope. • Findings reconcile Teeling’s dual-loop model with modern cryo-EM data, providing insights for scFv affinity tuning in CAR-T design.
- 1 March 2026
- Published by American Association for the Advancement of Science (AAAS) in Computational and Structural Biotechnology Journal
- Vol. 35 (1)
Open AccessRevisiting the Ofatumumab Epitope on CD20 through Integrative Molecular Dynamics and Flow Cytometry Analyses
Highlights: • How does ofatumumab recognize CD20? Revisiting conflicting epitope models from Teeling, Du, and Kumar • Integrative approach combining molecular dynamics, free-energy decomposition, and flow cytometry validation • MD and Δ G _res analyses define an ECL2b-centered epitope consistent with cryo-EM observations by Kumar et al. • Residues Tyr107, Asp99, Tyr169, and Arg228 form a stabilizing hydrophobic–electrostatic cluster in the paratope. • Findings reconcile Teeling’s dual-loop model with modern cryo-EM data, providing insights for scFv affinity tuning in CAR-T design.
- 5 November 2025
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 333 (Pt 2) , 148804
Structural and biochemical characterization of a thermostable Bacillus subtilis L-asparaginase with antiproliferative effects on hematological cancer cell lines
- 5 November 2025
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 333 (Pt 2) , 148804
Structural and biochemical characterization of a thermostable Bacillus subtilis L-asparaginase with antiproliferative effects on hematological cancer cell lines
- 7 July 2025
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 320 (Pt 2) , 145831
Linker-dependent modulation of anti-CD22 scFv antibody stability and avidity: Combined structural and experimental insights
- 7 July 2025
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 320 (Pt 2) , 145831
Linker-dependent modulation of anti-CD22 scFv antibody stability and avidity: Combined structural and experimental insights
- 1 July 2024
- Published by Human Kinetics in Journal of Physical Activity and Health
- Vol. 21 (7) , 717-725
Physical Activity at Different Life Stages and Its Consequence on the Initial Immunization and Inflammatory Response Against COVID-19
Background : To evaluate the influence of previous physical activity (PA) during childhood, adolescence, and current PA practice on the production of antibodies and inflammatory response between the first and second doses of the COVID-19 vaccine. Methods : Fifty-nine men and 56 women were evaluated before the first vaccine, and 12 weeks later, blood samples were taken to quantify production of anti-severe acute respiratory syndrome coronavirus-2 immunoglobulin G antibodies and cytokines. Previous PA during childhood and adolescence was self-referred, and current PA was assessed using the International Physical Activity Questionnaire. Results : A positive and significant association was observed only between PA practice during adolescence and an increase in antibody production in adulthood ( β = 2012.077, 95% confidence interval, 257.7953–3766.358, P = .025). Individuals who practiced PA during adolescence showed higher production of antibodies between the first and second vaccine dose compared to nonpractitioners ( P = .025) and those that accumulated ≥150 minutes per week of current moderate–vigorous PA (MVPA), and presented higher antibody production in relation to who did P = .046). Individuals that were practitioners during childhood produced higher G-CSF ( P = .047), and those that accumulated ≥150 minutes per week of current MVPA demonstrated lower IP-10 levels ( P = .033). However, PA practitioners during adolescence presented higher G-CSF ( P = .025), IL-17 ( P = .038), IL-1RA ( P = .005), IL-1β ( P = .020), and IL-2 ( P = .026) levels. Conclusion : Our results suggest that adults that accumulated at least 150 minutes of MVPA per week or practiced PA during adolescence developed an improved immune and inflammatory response against COVID-19 vaccination.
- 1 July 2024
- Published by Human Kinetics in Journal of Physical Activity and Health
- Vol. 21 (7) , 717-725
Physical Activity at Different Life Stages and Its Consequence on the Initial Immunization and Inflammatory Response Against COVID-19
Background : To evaluate the influence of previous physical activity (PA) during childhood, adolescence, and current PA practice on the production of antibodies and inflammatory response between the first and second doses of the COVID-19 vaccine. Methods : Fifty-nine men and 56 women were evaluated before the first vaccine, and 12 weeks later, blood samples were taken to quantify production of anti-severe acute respiratory syndrome coronavirus-2 immunoglobulin G antibodies and cytokines. Previous PA during childhood and adolescence was self-referred, and current PA was assessed using the International Physical Activity Questionnaire. Results : A positive and significant association was observed only between PA practice during adolescence and an increase in antibody production in adulthood ( β = 2012.077, 95% confidence interval, 257.7953–3766.358, P = .025). Individuals who practiced PA during adolescence showed higher production of antibodies between the first and second vaccine dose compared to nonpractitioners ( P = .025) and those that accumulated ≥150 minutes per week of current moderate–vigorous PA (MVPA), and presented higher antibody production in relation to who did P = .046). Individuals that were practitioners during childhood produced higher G-CSF ( P = .047), and those that accumulated ≥150 minutes per week of current MVPA demonstrated lower IP-10 levels ( P = .033). However, PA practitioners during adolescence presented higher G-CSF ( P = .025), IL-17 ( P = .038), IL-1RA ( P = .005), IL-1β ( P = .020), and IL-2 ( P = .026) levels. Conclusion : Our results suggest that adults that accumulated at least 150 minutes of MVPA per week or practiced PA during adolescence developed an improved immune and inflammatory response against COVID-19 vaccination.
- Open Access
Progress on Phage Display Technology: Tailoring Antibodies for Cancer Immunotherapy
The search for innovative anti-cancer drugs remains a challenge. Over the past three decades, antibodies have emerged as an essential asset in successful cancer therapy. The major obstacle in developing anti-cancer antibodies is the need for non-immunogenic antibodies against human antigens. This unique requirement highlights a disadvantage to using traditional hybridoma technology and thus demands alternative approaches, such as humanizing murine monoclonal antibodies. To overcome these hurdles, human monoclonal antibodies can be obtained directly from Phage Display libraries, a groundbreaking tool for antibody selection. These libraries consist of genetically engineered viruses, or phages, which can exhibit antibody fragments, such as scFv or Fab on their capsid. This innovation allows the in vitro selection of novel molecules directed towards cancer antigens. As foreseen when Phage Display was first described, nowadays, several Phage Display-derived antibodies have entered clinical settings or are undergoing clinical evaluation. This comprehensive review unveils the remarkable progress in this field and the possibilities of using clever strategies for phage selection and tailoring the refinement of antibodies aimed at increasingly specific targets. Moreover, the use of selected antibodies in cutting-edge formats is discussed, such as CAR (chimeric antigen receptor) in CAR T-cell therapy or ADC (antibody drug conjugate), amplifying the spectrum of potential therapeutic avenues.
Open AccessProgress on Phage Display Technology: Tailoring Antibodies for Cancer Immunotherapy
The search for innovative anti-cancer drugs remains a challenge. Over the past three decades, antibodies have emerged as an essential asset in successful cancer therapy. The major obstacle in developing anti-cancer antibodies is the need for non-immunogenic antibodies against human antigens. This unique requirement highlights a disadvantage to using traditional hybridoma technology and thus demands alternative approaches, such as humanizing murine monoclonal antibodies. To overcome these hurdles, human monoclonal antibodies can be obtained directly from Phage Display libraries, a groundbreaking tool for antibody selection. These libraries consist of genetically engineered viruses, or phages, which can exhibit antibody fragments, such as scFv or Fab on their capsid. This innovation allows the in vitro selection of novel molecules directed towards cancer antigens. As foreseen when Phage Display was first described, nowadays, several Phage Display-derived antibodies have entered clinical settings or are undergoing clinical evaluation. This comprehensive review unveils the remarkable progress in this field and the possibilities of using clever strategies for phage selection and tailoring the refinement of antibodies aimed at increasingly specific targets. Moreover, the use of selected antibodies in cutting-edge formats is discussed, such as CAR (chimeric antigen receptor) in CAR T-cell therapy or ADC (antibody drug conjugate), amplifying the spectrum of potential therapeutic avenues.
- 20 October 2022
- Published by Cambridge University Press (CUP) in Zygote
- Vol. 31 (1) , 31-43
In vivo and in vitro matured bovine oocytes present a distinct pattern of single-cell gene expression
Summary: Oocyte gene expression is a well controlled event that promotes gamete competence to undergo maturation, fertilization, and to support early embryo development, directly affecting reproductive outcomes. Considering that in vivo controlled ovarian stimulation or in vitro maturation (IVM) for the acquisition of mature oocytes has distinct implications for gene expression, we sought to evaluate the effects of these procedures on the expression of competence-related genes in single-cell oocytes. Healthy Nelore cows of reproductive age were synchronized to harvest in vivo matured oocytes; ovaries from slaughtered animals were used to obtain cumulus–oocyte complexes that were in vitro matured. Single-cell gene expression was performed using TaqMan Low-Density Arrays and 42 genes were evaluated. In silico analysis of protein interactions and Gene Ontology (GO) analysis was performed. Reduced gene expression was observed for 24 targets in IVM oocytes when compared with those of in vivo matured oocytes (P < 0.05). Differences ranged from 1.5-fold to 4.8-fold higher in in vivo oocytes and the BMP15 (5.28), GDF9 (6.23), NOBOX (7.25), HSPA8 (7.85) and MSX1 (11.00) showed the greatest fold increases. The strongest score of functional interactions was observed between the CDC20 and CKS2, with the differentially expressed gene CDC20 being the main marker behind GO enrichment. IVM negatively affected the expression of important genes related to oocyte competency, and showed higher expression levels in in vivo matured oocytes. In vivo controlled ovarian stimulation may be a better strategy to achieve proper oocyte competence and increase the success of assisted reproductive technologies.
- 20 October 2022
- Published by Cambridge University Press (CUP) in Zygote
- Vol. 31 (1) , 31-43
In vivo and in vitro matured bovine oocytes present a distinct pattern of single-cell gene expression
Summary: Oocyte gene expression is a well controlled event that promotes gamete competence to undergo maturation, fertilization, and to support early embryo development, directly affecting reproductive outcomes. Considering that in vivo controlled ovarian stimulation or in vitro maturation (IVM) for the acquisition of mature oocytes has distinct implications for gene expression, we sought to evaluate the effects of these procedures on the expression of competence-related genes in single-cell oocytes. Healthy Nelore cows of reproductive age were synchronized to harvest in vivo matured oocytes; ovaries from slaughtered animals were used to obtain cumulus–oocyte complexes that were in vitro matured. Single-cell gene expression was performed using TaqMan Low-Density Arrays and 42 genes were evaluated. In silico analysis of protein interactions and Gene Ontology (GO) analysis was performed. Reduced gene expression was observed for 24 targets in IVM oocytes when compared with those of in vivo matured oocytes (P < 0.05). Differences ranged from 1.5-fold to 4.8-fold higher in in vivo oocytes and the BMP15 (5.28), GDF9 (6.23), NOBOX (7.25), HSPA8 (7.85) and MSX1 (11.00) showed the greatest fold increases. The strongest score of functional interactions was observed between the CDC20 and CKS2, with the differentially expressed gene CDC20 being the main marker behind GO enrichment. IVM negatively affected the expression of important genes related to oocyte competency, and showed higher expression levels in in vivo matured oocytes. In vivo controlled ovarian stimulation may be a better strategy to achieve proper oocyte competence and increase the success of assisted reproductive technologies.
- 14 May 2022
- Published by Springer Nature
- p. 281-314
CAR-T Cells and Other Related Technologies